Trane Technologies plc vs Zimmer Biomet Holdings Inc — how do they compare? Trane Technologies plc trades at $471.85 (market cap $105.17B), while Zimmer Biomet Holdings Inc trades at $92.24 (market cap $17.56B). The key difference: Trane Technologies plc is far larger — about 6× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.04%). Which is the better fit depends on your goals.
| TT | ZBH | |
|---|---|---|
Market Cap | $105.17B | $17.56B |
Volume | 1,040,183 | 2,298,426 |
Sector | Industrials | Health |
52-Week High | $503.46 | $103.98 |
52-Week Low | $376.43 | $79.58 |
Enterprise Value | $108.47B | $24.63B |
Dividend Yield | 0.88% | 1.04% |
Typical Hold Time | — | 89 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zimmer Biomet (ZBH) trades at $91.77, down 0.43% on the day, with a bullish technical signal supported by moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.07 exceeding expectations. Revenue growth remains steady at $8.23B for 2025, though net income margins have moderated from 13.84% in 2023 to 8.56% in 2025. The company maintains strong profitability with a 69.87% gross margin and recently announced a $0.24 quarterly dividend.
ZBH presents a mixed outlook with positive earnings momentum and analyst consensus price target of $103.11 offering 12% upside potential. However, rising debt levels and competitive pressures in medical technology pose risks. Institutional ownership trends show continued interest, with State Street increasing its position by 0.6% in Q3 2026. The stock's valuation at 22.35 P/E appears reasonable given the company's market leadership position.
Trailing returns across standard periods
Latest headlines on both assets
Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →